TapImmune tapimmune.com

TapImmune is a leader in the development of novel immunotherapies for cancer, with multiple Phase 2 and Phase 1b/2 clinical studies currently ongoing for the treatment of ovarian and breast cancer. The company's peptide- or nucleic acid-based immunotherapeutic products comprise multiple naturally processed epitopes (NPEs) designed to comprehensively stimulate a patient's killer T-cells and helper T-cells, and to restore or further augment antigen presentation by using proprietary nucleic acid-ba...Show all

TapImmune is a leader in the development of novel immunotherapies for cancer, with multiple Phase 2 and Phase 1b/2 clinical studies currently ongoing for the treatment of ovarian and breast cancer. The company's peptide- or nucleic acid-based immunot...Show all

See All Exits Recent Exits

Phone: 904-862-6490

Fax:

5 West Forsyth Street

Jacksonville, 32202
Florida, United States

TapImmune - Investments & Acquisitions

Show Real Data TapImmune Investments
See all Recent Investments
Date Company Round Amount Co-investors
2018-05-15Marker TherapeuticsMerger
See all 1 investments